Australia's Island Pharmaceuticals rises on agreement extension with US Army
10/06/2026 06:56
BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army ** Shares of Australia's Island Pharmaceuticals ILA.AX rise as much as 5.7% to A$0.37, their biggest intraday pct gain since May 21
** The antiviral drug developer says it extends its existing cooperative research and development agreement (CRADA) with the U.S. Army
** Says the agreement advances the company's dose optimisation study evaluating Galidesivir for the treatment of fatal viral fever, Marburg Virus Disease
** Says this allows company to prepare for operations and commercialization of the drug
** YTD, stock down 15.1%, including day's moves
(Reporting by Aamir Sheik Khalid in Bengaluru)
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic